These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1283959)

  • 1. Low incidence of pulmonary Pseudomonas cepacia infection in Danish cystic fibrosis patients.
    Nir M; Johansen HK; Høiby N
    Acta Paediatr; 1992 Dec; 81(12):1042-3. PubMed ID: 1283959
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia.
    Jacques I; Derelle J; Weber M; Vidailhet M
    Eur J Pediatr; 1998 May; 157(5):427-31. PubMed ID: 9625343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of pulmonary colonization with Burkholderia cepacia in cystic fibrosis patients. The French Observatoire Burkholderia cepacia Study Group.
    Segonds C; Chabanon G; Couetdic G; Michel-Briand Y; Bingen E
    Eur J Clin Microbiol Infect Dis; 1996 Oct; 15(10):841-2. PubMed ID: 8950569
    [No Abstract]   [Full Text] [Related]  

  • 4. Burkholderia cepacia in cystic fibrosis.
    LiPuma JJ; Stull TL
    N Engl J Med; 1995 Mar; 332(12):820; author reply 820-1. PubMed ID: 7532286
    [No Abstract]   [Full Text] [Related]  

  • 5. Pseudomonas cepacia in the sputum of cystic fibrosis patients.
    Taylor PC; Kalamatianos CC
    Pathology; 1994 Jul; 26(3):315-7. PubMed ID: 7527513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkholderia cepacia in cystic fibrosis.
    Govan JR
    N Engl J Med; 1995 Mar; 332(12):819-20; author reply 820-1. PubMed ID: 7532285
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation and treatment of cystic fibrosis patients with lung infections caused by Pseudomonas (Burkholderia) cepacia and multiresistant Pseudomonas aeruginosa.
    Høiby N
    Neth J Med; 1995 Jun; 46(6):280-7. PubMed ID: 7643943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temocillin and cystic fibrosis: outcome of intravenous administration in patients infected with Pseudomonas cepacia.
    Taylor RF; Gaya H; Hodson ME
    J Antimicrob Chemother; 1992 Mar; 29(3):341-4. PubMed ID: 1375595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of N-acyl-L-homoserine lactones by P. aeruginosa isolates from chronic lung infections associated with cystic fibrosis.
    Geisenberger O; Givskov M; Riedel K; Høiby N; Tümmler B; Eberl L
    FEMS Microbiol Lett; 2000 Mar; 184(2):273-8. PubMed ID: 10713433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of mucoid Pseudomonas aeruginosa from clinical sources.
    Doggett RG
    Appl Microbiol; 1969 Nov; 18(5):936-7. PubMed ID: 4984207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burkholderia cepacia in cystic fibrosis.
    Mahenthiralingam E; Campbell M; Speert DP
    N Engl J Med; 1995 Mar; 332(12):819. PubMed ID: 7532284
    [No Abstract]   [Full Text] [Related]  

  • 12. Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen.
    Johansen HK; Kovesi TA; Koch C; Corey M; Høiby N; Levison H
    Pediatr Pulmonol; 1998 Aug; 26(2):89-96. PubMed ID: 9727758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial contaminants in cosmetic products from a patient with cystic fibrosis.
    O'Gorman K; Xu J; Elborn JS; Boyle L; Millar BC; Goldsmith CE; Moore JE
    Br J Biomed Sci; 2006; 63(3):141-2. PubMed ID: 17058716
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients.
    Pedersen SS; Jensen T; Høiby N; Koch C; Flensborg EW
    Acta Paediatr Scand; 1987 Nov; 76(6):955-61. PubMed ID: 3425313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.
    Govan JR
    J R Soc Med; 2000; 93 Suppl 38(Suppl 38):40-5. PubMed ID: 10911818
    [No Abstract]   [Full Text] [Related]  

  • 16. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
    Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W
    Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequencing of the Pseudomonas aeruginosa and Burkholderia cepacia genomes and their applications in relation to cystic fibrosis.
    Miller DA; Mahenthiralingam E
    J R Soc Med; 2003; 96 Suppl 43(Suppl 43):57-65. PubMed ID: 12906327
    [No Abstract]   [Full Text] [Related]  

  • 18. Pseudomonas cepacia: pulmonary infection in patients with cystic fibrosis.
    Taylor RF; Gaya H; Hodson ME
    Respir Med; 1993 Apr; 87(3):187-92. PubMed ID: 7684530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis.
    Ernst RK; Moskowitz SM; Emerson JC; Kraig GM; Adams KN; Harvey MD; Ramsey B; Speert DP; Burns JL; Miller SI
    J Infect Dis; 2007 Oct; 196(7):1088-92. PubMed ID: 17763333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis.
    Steinbach S; Sun L; Jiang RZ; Flume P; Gilligan P; Egan TM; Goldstein R
    N Engl J Med; 1994 Oct; 331(15):981-7. PubMed ID: 7521938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.